TREA

79304130 - AFFIDX

Follow

Information

  • Trademark
  • 79304130
  • Serial Number
    79304130
  • Registration Number
    6829613
  • Filing Date
    September 22, 2020
    4 years ago
  • Registration Date
    August 30, 2022
    2 years ago
  • Transaction Date
    December 28, 2022
    2 years ago
  • Status Date
    August 30, 2022
    2 years ago
  • Published for Opposition Date
    June 14, 2022
    2 years ago
  • Location Date
    August 30, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    OAKES, JEFFREY ALLEN
  • Attorney Name
    Alexandra MacKay
    Law Office Assigned Location Code
    O10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AFFIDX
Case File Statements
  • GS0091: Downloadable software in the nature of mobile application software for medical diagnostics; Downloadable software in the nature of mobile application software for the collection, analysis and reporting of diagnostic tests; downloadable mobile application software for the collection, analysis and reporting of diagnostic tests for Covid-19 and influenza
  • GS0051: Diagnostic testing materials, namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for medical testing purposes namely for testing for the detection and diagnosis of covid-19 and influenza; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza; diagnostic reagents for medical purposes; diagnostic testing materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes for the detection and diagnosis of covid-19 and influenza; diagnostic preparations for medical testing purposes; materials namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, and medical diagnostic strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza, and diagnostic reagents for medical testing purposes, all for the detection and diagnosis of covid-19 and influenza
  • GS0441: Medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; medical testing being medical testing for diagnostic or treatment purposes and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; advisory and information services relating to all the aforesaid
  • GS0101: Medical testing apparatus, instruments and equipment for diagnostic use namely apparatus for medical diagnostic testing for the detection and diagnosis of covid-19 and influenza; medical testing apparatus, instruments and equipment for the detection and diagnosis of Covid-19 and influenza, namely medical diagnostic apparatus for testing for viruses, medical diagnostic instruments for the analysis of body fluids, apparatus for virus testing purposes
Case File Event Statements
  • 12/28/2022 - 2 years ago
    38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/7/2022 - 2 years ago
    37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/7/2022 - 2 years ago
    36 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/30/2022 - 2 years ago
    35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/30/2022 - 2 years ago
    34 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/30/2022 - 2 years ago
    33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/1/2022 - 2 years ago
    32 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 7/13/2022 - 2 years ago
    31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/13/2022 - 2 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 7/5/2022 - 2 years ago
    29 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 6/14/2022 - 2 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/14/2022 - 2 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/8/2022 - 2 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/8/2022 - 2 years ago
    25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/25/2022 - 2 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/9/2022 - 2 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/9/2022 - 2 years ago
    22 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/9/2022 - 2 years ago
    21 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/9/2022 - 2 years ago
    20 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/2/2022 - 2 years ago
    19 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 4/18/2022 - 2 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/18/2022 - 2 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/18/2022 - 2 years ago
    16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 8/31/2021 - 3 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 8/31/2021 - 3 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 8/31/2021 - 3 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/4/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/4/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/4/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/15/2021 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/22/2021 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/22/2021 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/16/2021 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/13/2021 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/12/2021 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/12/2021 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/12/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/11/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR